Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 13, 2026Clinical Laboratory

Clinicopathological Characteristics and Prognostic Factors in Angioimmunoblastic T-cell Lymphoma: a Retrospective Analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

JWJing WangStamford International UniversityLGLifu GuoHubei University of Technology

Discussion

Loading...

Member takes

Implication

This retrospective analysis identifies prognostic factors in angioimmunoblastic T-cell lymphoma, suggesting new treatment options.

Key Points

  • The aim is to examine the clinicopathological characteristics and prognostic factors in angioimmunoblastic T-cell lymphoma (AITL).
  • Conducted a retrospective analysis of patient data with AITL
  • Evaluated laboratory parameters related to prognosis
  • Assessed survival outcomes associated with PD-1 positivity
  • Identified several accessible laboratory parameters as significant prognostic factors
  • Noted that PD-1 positivity may have a protective effect on survival outcomes
  • Confirmed that CHOP/CHOPE is the standard treatment but targeted therapies may enhance outcomes

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/698ebf1d85a1ff6a9301651bhttps://doi.org/10.7754/clin.lab.2025.250501
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Real-world study and prognostic analysis of angioimmunoblastic T-cell lymphoma2024 · 2 citations
  2. 2Integrating genomic and transcriptome features for characterization and prognostic prediction of angioimmunoblastic T-cell lymphoma2025
  3. 3Single-cell transcriptomic mapping of immune heterogeneity across angioimmunoblastic T-cell lymphoma subtypes2026
  4. 4Deciphering tph cells as prognostic drivers of angioimmunoblastic T-cell lymphoma2025
  5. 5Incidence and Survival of Patients With Angioimmunoblastic T‐Cell Lymphoma: A Nationwide Population‐Based Study Using English Cancer Registration Data2026